Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
sugammadex zentiva
zentiva italia s.r.l. - sugammadex - sugammadex
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
sugammadex synthon
synthon bv - sugammadex - sugammadex
Evrópusambandið -
ítalska -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - blocco neuromuscolare - tutti gli altri prodotti terapeutici - inversione del blocco neuromuscolare indotto da rocuronio o vecuronio. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
sugammadex sandoz gmbh
sandoz gmbh - sugammadex - sugammadex
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
sugammadex qilu
qilu pharma spain s.l. - sugammadex - sugammadex
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
sugammadex aguettant
laboratoire aguettant - sugammadex - sugammadex
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
ateroid 200 50cps 200lru
cor.con. international srl - sulfomucopolisaccaridi - capsule - "24 mg capsule molli" 50 capsule - heparin group
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
ateroid im 6f 2ml 250lru
cor.con. international srl - sulfomucopolisaccaridi - preparazione iniettabile - im 6 f 2 ml 250 lru - heparin group
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
hemovasal
far.g.im. s.r.l. - eparinici - eparinici
Evrópusambandið -
ítalska -
EMA (European Medicines Agency)
rapilysin
actavis group ptc ehf - reteplase - infarto miocardico - agenti antitrombotici - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.